From Bio Co., Ltd. (377220) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for From Bio Co., Ltd. (377220:KRX), powered by AI.

Current Price
₩773
P/E Ratio
-1.0
Market Cap
21.9B
Sector
Consumer Defensive
What is the From Bio Co., Ltd. stock price forecast?

From Bio Co., Ltd. is currently trading at ₩773. View real-time AI analysis on Alpha Lenz.

What is From Bio Co., Ltd. insider trading activity?

View the latest insider trading data for From Bio Co., Ltd. on Alpha Lenz.

What is From Bio Co., Ltd.'s P/E ratio?

From Bio Co., Ltd.'s P/E ratio is -1.0.

From Bio Co., Ltd.

KRX · 377220
₩773+23(+3.07%)Market closedKRX regular session 09:00–15:30 KST
Ask about From Bio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

From Bio Co., Ltd. trades at a P/E of -1.0 (undervalued) with modest ROE of -57.4%.

Ask for details

Company Overview

From Bio Co., Ltd. is a biotechnology company engaged in the development and commercialization of innovative healthcare solutions. Primarily focusing on the pharmaceutical and nutraceutical segments, From Bio leverages advanced biotechnological research to address a wide range of health conditions. The company's core product offerings include dietary supplements, functional foods, and health aids that aim to promote wellness and preventive healthcare. By integrating natural ingredients with cutting-edge biotechnology, From Bio Co., Ltd. addresses the growing consumer demand for scientifically supported health products. The firm operates in both domestic and international markets, serving diverse sectors such as personalized nutrition, lifestyle enhancement, and over-the-counter healthcare. With its commitment to quality and innovation, From Bio plays a significant role in the biopharmaceutical industry, contributing to the development of products that support sustainable health solutions for a global audience. By continuing to focus on research and expanding its portfolio, the company strengthens its market presence and fosters advancements in the biotech sector.

CEO심태진
SectorConsumer Defensive
IndustryPackaged Foods
0

Company Statistics

FY 2025

Profile

₩21,883,630,000Market Cap
₩72,162,174,410Revenue
28.31MShares Out
0Employees

Margins

57.58%Gross
-23.55%EBITDA
-25.78%Operating
-28.93%Pre-Tax
-32.15%Net

Valuation

-0.97P/E
0.78P/B
0.30EV/Sales
-3.13EV/EBITDA
-1.93P/FCF

Growth (CAGR)

-10.10%Rev 3Yr
-7.76%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-31.69%ROA
-57.38%ROE
-26.51%ROIC

Financial Health

₩2,292,957,220Cash & Cash Equivalents
₩36,813,114,310Net Debt
149.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

From Bio Co., Ltd. (ticker: 377220) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). Market cap is $21.9B.

The current price is ₩773 with a P/E ratio of -0.97x and P/B of 0.78x.

ROE is -57.38% and operating margin is -25.78%. Annual revenue is $72.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
From Bio Co., Ltd. (377220) Stock Forecast 2026 ₩773 — Price, Financials & Analyst Targets | Alpha Lenz